CompletedPhase 2NCT04351373
Microscopic Fluorescence-guided Vestibular Schwannoma Resection Using Fluorescein Sodium and YELLOW 560
Studying Vestibular schwannoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Mayo Clinic
- Principal Investigator
- Matthew L Carlson, MDMayo Clinic
- Intervention
- Fluorescein Sodium(drug)
- Enrollment
- 12 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2021 – 2022
Study locations (1)
- Mayo Clinic in Rochester, Rochester, Minnesota, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04351373 on ClinicalTrials.govOther trials for Vestibular schwannoma
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONNCT07503613Long Term Follow-up Study of AAVAnc80-antiVEGF Gene TherapyAkouos, Inc.
- RECRUITINGNANCT07364955Vestibular Rehabilitation Protocol in Unilateral Vestibular SchwannomaAlbert Torrents Torrero
- ACTIVE NOT RECRUITINGNANCT07130851Mapping of Vestibular Centers Activation Using fMRI in Patients With Vestibular SchwannomaMarketa Bonaventurova
- RECRUITINGNANCT06660082Early Rehabilitation Using Head Impulse Test for Acute Vestibular DeficitHospices Civils de Lyon
- RECRUITINGPHASE1, PHASE2NCT06517888Anti-VEGF Gene Therapy Trial for Vestibular SchwannomaAkouos, Inc.
- RECRUITINGNANCT06572475USPIO Enhanced MR Imaging in CNS Tumours (UMIC)Northern Care Alliance NHS Foundation Trust
- RECRUITINGNANCT06112509Evolution of Vestibular Function After Treatment of a Vestibular Schwannoma by Gamma-knife Radio-surgeryCentre Hospitalier Universitaire de Besancon
- RECRUITINGNANCT05702749Evaluating Pre-Treatment Vestibular Physical Therapy Rehab for Patients With Vestibular SchwannomasMedical College of Wisconsin